These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18846867)

  • 1. [MSD and LIF on marketing studies: all clinical trials can be used in marketing].
    Bernadotte K; Bergström R
    Lakartidningen; 2008 Sep 17-23; 105(38):2594-5; author reply 2595. PubMed ID: 18846867
    [No Abstract]   [Full Text] [Related]  

  • 2. [Independent clinical trials are imperative].
    Gøtzsche PC
    Ugeskr Laeger; 2005 Apr; 167(14):1491-4. PubMed ID: 15887740
    [No Abstract]   [Full Text] [Related]  

  • 3. [Research and marketing].
    Meland E; Hernborg A
    Tidsskr Nor Laegeforen; 2004 Jul; 124(13-14):1820. PubMed ID: 15229677
    [No Abstract]   [Full Text] [Related]  

  • 4. [Coloured attitudes].
    Dejgaard A
    Ugeskr Laeger; 2008 Jan; 170(1):66. PubMed ID: 18219742
    [No Abstract]   [Full Text] [Related]  

  • 5. More Chinese get free drugs in clinical trials.
    Berton E
    Wall St J (East Ed); 2006 Feb; ():B1, B8. PubMed ID: 16528877
    [No Abstract]   [Full Text] [Related]  

  • 6. [No one is expected to ignore... the legal status of drug promotional studies].
    Cereghetti A
    Rev Med Suisse; 2006 Oct; 2(82):2307-10. PubMed ID: 17124859
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trials and tribulations. Allegations of waste: the 'seeding' study.
    Malakoff D
    Science; 2008 Oct; 322(5899):213. PubMed ID: 18845743
    [No Abstract]   [Full Text] [Related]  

  • 8. The pharma industry--redressing the balance.
    Panay N; Fenton A
    Climacteric; 2008 Oct; 11(5):353-4. PubMed ID: 18781478
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug companies, dermatologists, and the patient.
    Rapaport MJ; Franzblau M
    J Am Acad Dermatol; 2007 Feb; 56(2):333-4. PubMed ID: 17224376
    [No Abstract]   [Full Text] [Related]  

  • 10. [No bluff to be discovered in clinical trials].
    Berglund T
    Lakartidningen; 2009 Mar 25-31; 106(13):952-3. PubMed ID: 19441200
    [No Abstract]   [Full Text] [Related]  

  • 11. [ACCOMPLISH and the risks with company sponsored clinical trials].
    Furberg C
    Lakartidningen; 2009 Feb 11-17; 106(7):450. PubMed ID: 19350775
    [No Abstract]   [Full Text] [Related]  

  • 12. Researchers left to guess at outcomes of most cancer clinical trials.
    Twombly R
    J Natl Cancer Inst; 2009 Jan; 101(2):72-4. PubMed ID: 19141774
    [No Abstract]   [Full Text] [Related]  

  • 13. [Contact to the Danish Committees on Scientific Dishonesty is the logical step].
    Jensen IS
    Ugeskr Laeger; 2009 Apr; 171(15):1308; author reply 1308. PubMed ID: 19422162
    [No Abstract]   [Full Text] [Related]  

  • 14. Time to reverse that altruism bypass..
    Logan A
    Br J Gen Pract; 2002 May; 52(478):425. PubMed ID: 12014552
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of the European Clinical Trials Directive on published drug research in anaesthesia.
    Walker E; Hankins MC; White SM
    Anaesthesia; 2009 Sep; 64(9):984-9. PubMed ID: 19686484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Another way to tame the monster.
    Mansfield PR
    BMJ; 2006 Jul; 333(7560):202. PubMed ID: 16858067
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-clinical Post-Marketing Commitments for newly licenced pharmaceuticals.
    Reeve LM
    Regul Toxicol Pharmacol; 2009 Nov; 55(2):181-7. PubMed ID: 19589365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in the clinical development requirements for the marketing authorization of new medicines in southeast Asia.
    Kudrin A
    J Clin Pharmacol; 2009 Mar; 49(3):268-80. PubMed ID: 19168433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical trials with minors in Germany--effects of the 12th amendment to the German Drug Code on the numbers of applications to Institutional Review Boards (IRB)].
    Kölch M; Märsch C; Fegert JM; Lippert HD
    Gesundheitswesen; 2009 Mar; 71(3):127-33. PubMed ID: 19221985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial design and consequences for drug development for community-acquired pneumonia: an industry perspective.
    Tillotson GS; Echols RM
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S237-40. PubMed ID: 18986296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.